All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry

GDC-2394

CAS number:2238822-07-4    molecular formula:C20H25N5O4S

overview

compound introduction

GDC-2394 is an orally active and selective NLRP3 inhibitor, and also inhibits IL-1β with IC 50 s of 0.4 μM (human IL-1β) and 0.1 μM (mouse IL-1β). GDC-2394 inhibits NLRP3-induced caspase-1 activity without inhibiting NLRC4-dependent inflammasome activation. In Vitro GDC-2394 (20 μM; 30 min) inhibits NLRP3-induced apoptosis associated speck-like protein containing CARD (ASC) speck formation in THP-1 cells. GDC-2394 (1 nM-10 μM; 7 d) inhibits human macrophage IL-1β and IL-18 production after activation of the NLRP3 inflammasome. GDC-2394 (0-20 μM; 30 min) inhibits NLRP3-dependent caspase-1 activation (IC 50 =51 nM) in THP-1 cells, also inhibits NLRP3-dependent IL-1β release (IC 50 =63 nM) and NLRC4-dependent IL-1β release (IC 50 >20 μM) in mouse bone marrow-derived macrophages (mBMDMs). MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo GDC-2394 (compound 20) (1 mg/kg, 10 mg/kg; p.o.; single dose) inhibits production of IL-1β in an acute mouse peritonitis model . GDC-2394 (25 mg/kg; once daily for 7 d) reduces paw swelling and pain in a functional rat model of gouty arthritis . Preclinical PK of GDC-2394 . Species Mouse Rat Dog Cyno CL p (mL/min/kg) 10.1 1.3 11.7 4.1 V ss (L/kg) 0.72 0.29 0.67 0.18 T 1/2 (h) 1.2 4.4 0.99 0.89 %F (1 mg/kg) 80 33 78 53 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Acute mouse peritonitis model Dosage: 1 mg/kg and 10 mg/kg Administration: Oral gavage; 2 h later treated with 1.25 μg LPS (i.p.) followed by 1 mg monosodium urate crystals (i.p.) a further 2 h later. Result: Resulted in a dose-dependent decrease in peritoneal IL-1β concentrations after MSU treatment, and decreased the level of IL-1β by 66.8 and 81.3% at 1 and 10 mg/kg compared with the control. Animal Model: Functional rat model of gouty arthritis Dosage: 25 mg/kg Administration: Interventional injection; once daily for 7 days Result: Significantly inhibited knee swelling after 48 h. Form:Solid

Specs

Chinese alias-
English alias-
CAS number2238822-07-4molecular formulaC20H25N5O4S
molecular weight431.51 g/molExact mass≥99%
PSA-logp-

numbering system

No numbering system information yet

physicochemical properties

No physical and chemical property information yet

Safety information

No safety information yet

Production methods and uses

No production method and use information yet

Related

upstream information

No upstream information yet

downstream information

No downstream information yet

MSDS

Found 0 shareMSDS